Quote | SciSparc Ltd. (NASDAQ:SPRC)
Last: | $0.93 |
---|---|
Change Percent: | -4.76% |
Open: | $1.1 |
Close: | $0.93 |
High: | $1.1 |
Low: | $0.9131 |
Volume: | 1,858,245 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
News | SciSparc Ltd. (NASDAQ:SPRC)
2024-05-31 10:43:44 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Mind Medicine...
TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, ann...
Message Board Posts | SciSparc Ltd. (NASDAQ:SPRC)
Subject | By | Source | When |
---|---|---|---|
Yes, this one can't hold gains very long. | subslover | investorshub | 04/11/2023 11:29:16 PM |
They always hit this thing so hard... | Clean | investorshub | 04/11/2023 5:27:50 PM |
Nice pre-market volume. | subslover | investorshub | 04/11/2023 11:31:54 AM |
$SPRC moving higher. mb | Mt. Blanc | investorshub | 03/06/2023 1:03:24 PM |
SciSparc's Drug Discovery Joint Venture MitoCareX Bio Successfully | subslover | investorshub | 02/17/2023 1:59:38 PM |
News, Short Squeeze, Breakout and More Instantly...
SciSparc Ltd. Company Name:
SPRC Stock Symbol:
NASDAQ Market:
TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, ann...
PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....
SciSparc Ltd. (SPRC) is expected to report for quarter end 2023-12-31